ArticleEClinicalMedicine2023

Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension.

Steve Vucic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.